SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Taiwo N. Ngwa, Arthur Beyder, Santhi S. Vege, 84-Year-Old Man With Night Sweats, Weight Loss, and Diarrhea, Mayo Clinic Proceedings, 2014, 89, 3, 409

    CrossRef

  2. 2
    Bronwyn S. Berthon, Lesley K. MacDonald-Wicks, Lisa G. Wood, A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans, Nutrition Research, 2014, 34, 3, 179

    CrossRef

  3. 3
    A. Kavanaugh, A. F. Wells, Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis, Rheumatology, 2014,

    CrossRef

  4. 4
    Inmaculada Rincón, Daniel F. Battafarano, Jose F. Restrepo, John M. Erikson, Agustín Escalante, Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis, Arthritis & Rheumatology, 2014, 66, 2
  5. 5
    Karl Martin Wissing, Lissa Pipeleers, Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment, Transplantation Reviews, 2014, 28, 2, 37

    CrossRef

  6. 6
    Ezra Hahn, Normand Laperriere, Barbara-Ann Millar, James Oestreicher, Hugh McGowan, Hatem Krema, Harmeet Gill, Dan DeAngelis, Jeff Hurwitz, Nancy Tucker, Rand Simpson, Caroline Chung, Orbital radiation therapy for Graves’ ophthalmopathy: Measuring clinical efficacy and impact, Practical Radiation Oncology, 2014, 4, 4, 233

    CrossRef

  7. 7
    Laura E. Targownik, Zoann Nugent, Harminder Singh, Charles N. Bernstein, Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2014, 20, 4, 622

    CrossRef

  8. 8
    V. Phan, T. Blydt-Hansen, J. Feber, N. Alos, S. Arora, S. Atkinson, L. Bell, C. Clarson, R. Couch, E. A. Cummings, G. Filler, R. M. Grant, J. Grimmer, D. Hebert, B. Lentle, J. Ma, M. Matzinger, J. Midgley, M. Pinsk, C. Rodd, N. Shenouda, R. Stein, D. Stephure, S. Taback, K. Williams, F. Rauch, K. Siminoski, L. M. Ward, Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome, Osteoporosis International, 2014, 25, 2, 627

    CrossRef

  9. 9
    Steven P. Stanos, Mark D. Tyburski, Sagar S. Parikh, Practical Management of Pain, 2014,

    CrossRef

  10. 10
    Dora Liu, Alexandra Ahmet, Leanne Ward, Preetha Krishnamoorthy, Efrem D Mandelcorn, Richard Leigh, Jacques P Brown, Albert Cohen, Harold Kim, A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy, Allergy, Asthma & Clinical Immunology, 2013, 9, 1, 30

    CrossRef

  11. 11
    Bobby Kwanghoon Han, Ralph Yachoui, Kayoung Yi, Are ocular complications of a high-dose glucocorticoid treatment appropriately monitored in patients with rheumatic diseases?, Rheumatology International, 2013, 33, 11, 2951

    CrossRef

  12. 12
    L. Fardet, Effets indésirables métaboliques et cardiovasculaires des corticothérapies systémiques, La Revue de Médecine Interne, 2013, 34, 5, 303

    CrossRef

  13. 13
    L. Fardet, Effets métaboliques des hypercorticismes exogènes, Obésité, 2013, 8, 3, 160

    CrossRef

  14. 14
    Kiyoshi Migita, Yasuharu Sasaki, Naoki Ishizuka, Toru Arai, Tetsuyuki Kiyokawa, Eiichi Suematsu, Mitsuhiro Yoshimura, Yojiro Kawabe, Ryutaro Matsumura, Shinobu Akagawa, Shunsuke Mori, Masahiro Shirai, Yukio Watanabe, Naoya Minami, Takayoshi Soga, Isoko Owan, Shiro Ohshima, Shigeru Yoshizawa, Toshihiro Matsui, Shigeto Tohma, Seiji Bito, Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease, Medicine, 2013, 92, 5, 285

    CrossRef

  15. 15
    Gert-Jan Braunstahl, Jan Chlumský, Guy Peachey, Chien-Wei Chen, Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting, Allergy, Asthma & Clinical Immunology, 2013, 9, 1, 47

    CrossRef

  16. 16
    Robert A. Adler, Robert S. Weinstein, Kenneth G. Saag, Osteoporosis, 2013,

    CrossRef

  17. 17
    G. Ruiz-Irastorza, G. Espinosa, M.A. Frutos, J. Jiménez Alonso, M. Praga, L. Pallarés, F. Rivera, Á. Robles Marhuenda, A. Segarra, C. Quereda, Diagnóstico y tratamiento de la nefritis lúpica, Revista Clínica Española, 2012, 212, 3, 147.e1

    CrossRef

  18. 18
    Beatriz Y Hanaoka, Charlotte A Peterson, Leslie J Crofford, Glucocorticoid effects on skeletal muscle: benefit and risk in patients with autoimmune inflammatory rheumatoid diseases, Expert Review of Clinical Immunology, 2012, 8, 8, 695

    CrossRef

  19. 19
    Marianne Sidoroff, Kaija-Leena Kolho, Glucocorticoids in pediatric inflammatory bowel disease, Scandinavian Journal of Gastroenterology, 2012, 47, 7, 745

    CrossRef

  20. 20
    Celia Rodd, Bianca Lang, Timothy Ramsay, Nathalie Alos, Adam M. Huber, David A. Cabral, Rosie Scuccimarri, Paivi M. Miettunen, Johannes Roth, Stephanie A. Atkinson, Robert Couch, Elizabeth A. Cummings, Peter B. Dent, Janet Ellsworth, John Hay, Kristin Houghton, Roman Jurencak, Maggie Larché, Claire LeBlanc, Kiem Oen, Claire Saint-Cyr, Robert Stein, David Stephure, Shayne Taback, Brian Lentle, Maryann Matzinger, Nazih Shenouda, David Moher, Frank Rauch, Kerry Siminoski, Leanne M. Ward, Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: A national observational study, Arthritis Care & Research, 2012, 64, 1
  21. 21
    Menachem Rottem, Omalizumab Reduces Corticosteroid Use in Patients with Severe Allergic Asthma: Real-Life Experience in Israel, Journal of Asthma, 2012, 49, 1, 78

    CrossRef

  22. 22
    Sergei A. Grando, Pemphigus autoimmunity: Hypotheses and realities, Autoimmunity, 2012, 45, 1, 7

    CrossRef

  23. 23
    Gidon Berger, Emilia Hardak, Beatrice Shaham, Emili Avitan, Mordechai Yigla, Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing, Sleep and Breathing, 2012, 16, 2, 549

    CrossRef

  24. 24
    A. Sainsbury, L. Zhang, Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit, Obesity Reviews, 2012, 13, 3
  25. 25
    J. Feber, I. Gaboury, A. Ni, N. Alos, S. Arora, L. Bell, T. Blydt-Hansen, C. Clarson, G. Filler, J. Hay, D. Hebert, B. Lentle, M. Matzinger, J. Midgley, D. Moher, M. Pinsk, F. Rauch, C. Rodd, N. Shenouda, K. Siminoski, L. M. Ward, Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome, Osteoporosis International, 2012, 23, 2, 751

    CrossRef

  26. 26
    Bernhard K. Krämer, Marian Klinger, Štefan Vítko, Maciej Glyda, Karsten Midtvedt, Sergio Stefoni, Franco Citterio, Frank Pietruck, Jean-Paul Squifflet, Giuseppe Segoloni, Bernd Krüger, Heide Sperschneider, Bernhard Banas, Lars Bäckman, Markus Weber, Mario Carmellini, Ferenc Perner, Kerstin Claesson, Wojciech Marcinkowski, Marek Ostrowski, Grzegorz Senatorski, Johan Nordström, Kaija Salmela, Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation, Transplantation Journal, 2012, 94, 5, 492

    CrossRef

  27. 27
    Jennifer Beebe-Dimmer, Hal Morgenstern, Karynsa Cetin, Cecilia Yee, Monina Bartoces, Vahakn Shahinian, Jon Fryzek, John Acquavella, Kendra L. Schwartz, Androgen Deprivation Therapy and Cataract Incidence Among Elderly Prostate Cancer Patients in the United States, Annals of Epidemiology, 2011, 21, 3, 156

    CrossRef

  28. 28
    Carol J Waudby, Richard L Berg, James G Linneman, Luke V Rasmussen, Peggy L Peissig, Lin Chen, Catherine A McCarty, Cataract research using electronic health records, BMC Ophthalmology, 2011, 11, 1, 32

    CrossRef

  29. 29
    Gabriela Schmajuk, Jinoos Yazdany, Drug Monitoring in Systemic Lupus Erythematosus: A Systematic Review, Seminars in Arthritis and Rheumatism, 2011, 40, 6, 559

    CrossRef

  30. 30
    Cornelia M. Spies, Cindy Strehl, Marlies C. van der Goes, Johannes W.J. Bijlsma, Frank Buttgereit, Glucocorticoids, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 891

    CrossRef

  31. 31
    Wen-Hsiang Wu, Jia-You Liu, Hen-Hong Chang, Latent class model based diagnostic system utilizing traditional Chinese medicine for patients with systemic lupus erythematosus, Expert Systems with Applications, 2011, 38, 1, 281

    CrossRef

  32. 32
    Felix M. Arellano, Alejandro Arana, Charles E. Wentworth, Carlos Fernandez Vidaurre, Bradley E. Chipps, Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States, Pediatric Allergy and Immunology, 2011, 22, 5
  33. 33
    M. Marenzana, K. Greenslade, A. Eddleston, R. Okoye, D. Marshall, A. Moore, M. K. Robinson, Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone, Arthritis & Rheumatism, 2011, 63, 8
  34. 34
    Kenneth G. Saag, Rheumatology, 2011,

    CrossRef

  35. 35
    Edgar Gerardo Durán Pérez, Everardo Alvarez Hernández, Aurora Elizabeth Serralde Zuñiga, Leslye Asela Lujano Nicolás, Oscar Moreno Loza, Antonio Segovia Palomo, Valentín Sánchez Pedraza, Sara Arellano Montaño, Comparación del índice de gravedad del síndrome de Cushing entre pacientes con origen endógeno y yatrogénico de la enfermedad, Endocrinología y Nutrición, 2010, 57, 9, 426

    CrossRef

  36. 36
    M. Molimard, R. Buhl, R. Niven, V. Le Gros, A. Thielen, J. Thirlwell, R. Maykut, G. Peachey, Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data, Respiratory Medicine, 2010, 104, 9, 1381

    CrossRef

  37. You have full text access to this OnlineOpen article37
    Pierluigi Fietta, Pieranna Fietta, Giovanni Delsante, Central nervous system effects of natural and synthetic glucocorticoids, Psychiatry and Clinical Neurosciences, 2009, 63, 5
  38. 38
    William F Lems, Piet P Geusens, Do the benefits of alendronate for premenopausal women on high-dose glucocorticoids outweigh the risks?, Nature Clinical Practice Rheumatology, 2009, 5, 2, 74

    CrossRef

  39. 39
    Faith Li-Ann CHIA, Bernard Yu-Hor THONG, Tang-Ching LAU, Pao-Hsii FENG, Recurrent fractures in an elderly patient with systemic lupus erythematosus, International Journal of Rheumatic Diseases, 2009, 12, 3
  40. 40
    Thomas H. Alexander, Michael H. Weisman, Jennifer M. Derebery, Mark A. Espeland, Bruce J. Gantz, A. Julianna Gulya, Paul E. Hammerschlag, Maureen Hannley, Gordon B. Hughes, Richard Moscicki, Ralph A. Nelson, John K. Niparko, Steven D. Rauch, Steven A. Telian, Patrick E. Brookhouser, Jeffrey P. Harris, Safety of High-Dose Corticosteroids for the Treatment of Autoimmune Inner Ear Disease, Otology & Neurotology, 2009, 30, 4, 443

    CrossRef

  41. 41
    Stephanie C. Manson, Ruth E. Brown, Annamaria Cerulli, Carlos Fernandez Vidaurre, The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use, Respiratory Medicine, 2009, 103, 7, 975

    CrossRef

  42. 42
    Johannes W.J. Bijlsma, Frank Buttgereit, Rheumatoid Arthritis, 2009,

    CrossRef

  43. 43
    Silvia Benemei, Paola Nicoletti, Pierangelo Geppetti, Mara Bonciani, Cataract in chronic cluster headache: two case reports and review of the literature, The Journal of Headache and Pain, 2008, 9, 6, 401

    CrossRef

  44. 44
    Peter K. Wung, Troy Anderson, Kevin R. Fontaine, Gary S. Hoffman, Ulrich Specks, Peter A. Merkel, Robert Spiera, John C. Davis, E. William St.Clair, W. Joseph McCune, John H. Stone, Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis, Arthritis Care & Research, 2008, 59, 5
  45. 45
    Rachel A Elliott, Poor Adherence to Medication in Adults with Rheumatoid Arthritis, Disease Management & Health Outcomes, 2008, 16, 1, 13

    CrossRef

  46. 46
    Allyson K McDonough, Jeffrey R Curtis, Kenneth G Saag, The epidemiology of glucocorticoid-associated adverse events, Current Opinion in Rheumatology, 2008, 20, 2, 131

    CrossRef

  47. 47
    Steven P. Stanos, Mark D. Tyburski, Raj's Practical Management of Pain, 2008,

    CrossRef

  48. 48
    Jeffrey R. Curtis, Kenneth G. Saag, Prevention and treatment of glucocorticoid-induced osteoporosis, Current Osteoporosis Reports, 2007, 5, 1, 14

    CrossRef

  49. 49
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2006, 15, 12
  50. 50
    Arthur Kavanaugh, Risks of glucocorticoid treatment—are they related to treatment duration and dosage?, Nature Clinical Practice Rheumatology, 2006, 2, 11, 588

    CrossRef

  51. 51
    Bryan Ballantyne, Ophthalmic Toxicology, General, Applied and Systems Toxicology,